
Edwards Lifesciences is a medical devices business based in the US. Edwards Lifesciences shares (EW) are listed on the NYSE and all prices are listed in US Dollars. Edwards Lifesciences employs 15,700 staff and has a trailing 12-month revenue of around $5.4 billion.
How to buy Edwards Lifesciences stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – EW. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
What's in this guide?
- EW shares summary
- Compare share dealing platforms
- Is EW stock a buy or sell?
- Stock performance over time
- Is EW suitable for ethical investing?
- Are EW shares over-valued?
- Edwards Lifesciences's financials
- How volatile are EW shares?
- Does Edwards Lifesciences pay a dividend?
- Have EW shares ever split?
- Other common questions
Edwards Lifesciences stock price (NYSE: EW)
Use our graph to track the performance of EW stocks over time.Edwards Lifesciences shares at a glance
Latest market close | $76.70 |
---|---|
52-week range | $67.13 - $131.10 |
50-day moving average | $75.28 |
200-day moving average | $90.77 |
Wall St. target price | $91.09 |
PE ratio | 33.2177 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $2.32 |
Buy Edwards Lifesciences stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Edwards Lifesciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Edwards Lifesciences price performance over time
Historical closes compared with the close of $76.7 from 2023-01-31
1 week (2023-01-25) | -1.27% |
---|---|
1 month (2022-12-30) | 2.80% |
3 months (2022-11-01) | 5.66% |
6 months (2022-08-01) | -22.88% |
1 year (2022-01-28) | -26.86% |
---|---|
2 years (2021-02-01) | -6.37% |
3 years (2020-01-31) | 219.86 |
5 years (2018-02-01) | 126.98 |
Is Edwards Lifesciences stock undervalued or overvalued?
Valuing Edwards Lifesciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Edwards Lifesciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Edwards Lifesciences's P/E ratio
Edwards Lifesciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Edwards Lifesciences shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Edwards Lifesciences's PEG ratio
Edwards Lifesciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0653. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Edwards Lifesciences's EBITDA
Edwards Lifesciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.8 billion.
The EBITDA is a measure of a Edwards Lifesciences's overall financial performance and is widely used to measure a its profitability.
Edwards Lifesciences financials
Revenue TTM | $5.4 billion |
---|---|
Operating margin TTM | 31.82% |
Gross profit TTM | $4 billion |
Return on assets TTM | 12.7% |
Return on equity TTM | 2481.14% |
Profit margin | 27.2% |
Book value | $10.04 |
Market capitalisation | $49.5 billion |
TTM: trailing 12 months
Edwards Lifesciences's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Edwards Lifesciences's total ESG risk score
Total ESG risk: 21.68
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences's overall score of 21.68 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Edwards Lifesciences's environmental score
Environmental score: 4.78/100
Edwards Lifesciences's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Edwards Lifesciences's social score
Social score: 13.43/100
Edwards Lifesciences's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Edwards Lifesciences's governance score
Governance score: 10.96/100
Edwards Lifesciences's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Edwards Lifesciences's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Edwards Lifesciences scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Edwards Lifesciences Corp was last rated for ESG on: 2019-01-01.
Total ESG score | 21.68 |
---|---|
Total ESG percentile | 24.1 |
Environmental score | 4.78 |
Environmental score percentile | 6 |
Social score | 13.43 |
Social score percentile | 6 |
Governance score | 10.96 |
Governance score percentile | 6 |
Level of controversy | 2 |
Edwards Lifesciences share dividends
We're not expecting Edwards Lifesciences to pay a dividend over the next 12 months.
Have Edwards Lifesciences's shares ever split?
Edwards Lifesciences's shares were split on a 3:1 basis on 31 May 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences shares which in turn could have impacted Edwards Lifesciences's share price.
Edwards Lifesciences share price volatility
Over the last 12 months, Edwards Lifesciences's shares have ranged in value from as little as $67.13 up to $131.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences's is 1.008. This would suggest that Edwards Lifesciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Edwards Lifesciences overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Edwards Lifesciences in the news
Edwards Lifesciences (EW) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Edwards Expects 2023 Sales To Outperform The 'Challenging Environment'
Edwards Lifesciences (EW) Q4 Earnings and Revenues Surpass Estimates
Frequently asked questions
What percentage of Edwards Lifesciences is owned by insiders or institutions?Currently 0.813% of Edwards Lifesciences shares are held by insiders and 85.052% by institutions. How many people work for Edwards Lifesciences?
Latest data suggests 15,700 work at Edwards Lifesciences. When does the fiscal year end for Edwards Lifesciences?
Edwards Lifesciences's fiscal year ends in December. Where is Edwards Lifesciences based?
Edwards Lifesciences's address is: One Edwards Way, Irvine, CA, United States, 92614 What is Edwards Lifesciences's ISIN number?
Edwards Lifesciences's international securities identification number is: US28176E1082 What is Edwards Lifesciences's CUSIP number?
Edwards Lifesciences's Committee on Uniform Securities Identification Procedures number is: 28176E108
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert